GlobeNewswire

Zageno and Thomas Scientific to Launch New, Fast and Easy Way to Choose and Purchase the Right Lab Products for Each Specific Experiment at Pittcon, Booth 2423

Dela

Continuously innovating to serve its customers better, century-old Thomas Scientific-the third largest and fastest-growing scientific-equipment company is leveraging startup Zageno, the largest and fastest-growing online marketplace dedicated to the research scientist. Zageno's new platform enables scientists to choose the best products to advance science using a ranking score based on millions of unbiased scientific publications; helps customers procure their products through better integration into their existing processes.

 

ORLANDO, Fla. USA and BERLIN, Germany, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Zageno Inc., an online biotech marketplace, and Thomas Scientific - a brand-centric, broad-line life-science-equipment, instrument, furniture, consumable, chemical, and laboratory safety supplier with nearly one million high-quality products - announced a U.S. commercial agreement, where Zageno will feature Thomas Scientific's full spectrum of offerings on the Zageno platform. Products are organized logically by process steps and methods (e.g. preparation gene editing; amplification separation: antibodies detection) so research scientists can search and order Thomas's portfolio of products easily, enabling more focus on performing their experiments instead of gathering supplies.

 

Commenting on its latest addition to its life science vendor partner list, Zageno Cofounder and Chief Revenue Officer Florian Wegener, M.D., M.B.A., Ph.D., said, "With its breadth of product offerings from world-leading brands, century-long commitment to serving the research community, and tireless focus on getting things right for customers - Thomas Scientific was a natural vendor partner for Zageno. We're proud to share their booth at Pittcon 2018, where we'll be honored to demonstrate how Zageno can make it easy for Thomas Scientific customers to save time and make better purchasing decisions for their specific scientific studies."

"We're thrilled to enter into this partnership with Zageno," said Thomas Scientific President and Chief Executive Officer Charles Simmons. "Zageno opened up a valuable channel for new customers, allowing us to optimize the focus of our field-based sales force. As an added benefit, Zageno has been able to integrate with our order-intake process, to make our operations more efficient, and make things easy and seamless for the customer."

In creating a biotech-specialized online marketplace, Zageno's founders recognized that scientific product comparison is different than comparing commercial products. Scientists need more information than is readily available on product packaging; nomenclature often varies from manufacturer to manufacturer making it difficult to compare "apples to apples"; and the stakes are high when choosing wrong. Using a non-optimal product in an experiment can lead to flawed data, poor, or non-reproducible results. To help scientists make the best choice possible, Zageno has created a proprietary application algorithm that not only compares specifications, but also incorporates an independent, unbiased "Zageno Scientific Score," based on millions of scientific publications. For the scientist, this simplifies the comparison process, helping her choose the best performing product for her particular experiment, helping to identify and purchase critical products for the work more reliably and driving down time and cost to scientific result.

"With my background in lean six sigma, I'm very conscious of what constitutes value-add time versus non-value-add time, and in biotech research - time spent performing well-designed, reproducible experiments is the ultimate in value-add time," said Zageno Cofounder and Chief Executive Officer David Pumberger, Ph.D. "We have created this marketplace to streamline supply chains and make it as painless and efficient as possible so that all the researcher has to focus on is his or her end point."

About Thomas Scientific ( www.thomassci.com ; twitter:  @ThomasSci )
Thomas Scientific provides the latest in equipment and supplies to the science community. In accordance to the tradition of the original founders, Thomas Scientific itself offers individualized customer service, innovative scientific equipment, and a comprehensive catalog offering a wide selection of product listings at a great deal. We are a registered contractor for the U.S. Federal Government. Thomas Scientific is committed to offering quality laboratory products while catering to the unique needs of the individual customer. For over a century, our dedication to provide the best in science equipment with personal, efficient service sets Thomas apart from the competition. Whether you work in a lab setting or perform your testing in the field, Thomas Scientific has the products you need. We carry everything you need from all of your favorite and trusted suppliers, including Ansell, Avantor(TM) Performance Materials, Becton Dickinson, Buchi, Corning, GE Healthcare, Globe Scientific, Eppendorf, JG Finneran/Porvair, Kimble, Mettler Toledo, Microflex, MilliporeSigma, Thermo Scientific, Wheaton, and more.

About Zageno Inc. ( www.zageno.com ;  twitter:  @ZAGENOteam )
Founded in 2015, Zageno is eliminating bottlenecks to breakthrough science and research through curated connections linking scientists and their institutions' procurement offices with leading life science vendors. World-renowned academic and government research facilities, global pharmaceutical companies, and biotechs large and small are already users of our unique online biotech marketplace, currently comprising more than three million products. What do we do? 1) We help scientists choose the optimal laboratory kits and materials for each unique experiment setup. 2) We make purchasing transactions more efficient for both buyers and sellers. 3) For our vendor partners, we provide a valuable, expanded sales channel. Our growing Zageno team of 50 in Boston, USA, and Berlin, Germany, includes experts in science, e-commerce, systems integration, and customer support to enable smarter, faster processes - allowing more time and resources for value-added science and better research results.

 

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/04a8c6dc-312c-4acb-826d-f8926c736be8

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7c42128a-faa4-40d4-aa2e-f662aa0a81dc

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6fb6f0ad-059d-4529-b2c8-a32e70601948

Caroline Grossman for Zageno
Mirepoix LLC
(781) 771-5579
Caroline@mirepoixllc.com

Diane Skala for Thomas Scientific
Thomas Scientific
(856) 832-3296
DianeS@thomassci.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ZAGENO, Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum